Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

Noble gas MRI research feasible, well-tolerated by patients

Pulmonary imaging research involving the use hyperpolarized noble gas MRI is feasible at smaller centers without significant human resources, according to a study published in the November issue of Academic Radiology.

Thumbnail

Clearer view: IR bests FBP for low-dose imaging of stones

Iterative reconstruction (IR) has been shown to improve image quality and diagnostic confidence in the identification of urinary stones with abdominal low-dose CT, according to a study published in the November issue of Academic Radiology.

Philips and Infraredx Sign Agreement for the Resale of Infraredx's TVC Imaging System Integrated with Philips' Interventional X-ray Systems

Royal Philips<http://www.philips.com/> (NYSE: PHG; AEX: PHIA) and Infraredx, Inc.<http://www.infraredx.com/>, a medical device company committed to advancing the diagnosis and management of coronary artery disease today announced a non-exclusive resale agreement for Infraredx's TVC Imaging System.  Under the terms of the agreement, Philips will sell Infraredx's TVC Imaging System alongside its Allura interventional X-ray systems in North America and Europe, expanding its interventional cardiology portfolio of advanced live image guidance solutions, clinical informatics and interventional tools.

Integra LifeSciences to Acquire DuraSeal(TM) Product Lines From Covidien

Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it has entered into a definitive agreement with Covidien to acquire the Confluent Surgical product lines, including surgical sealants, adhesion barrier, and, most importantly, DuraSeal(TM). The companies expect to complete this transaction by the end of the first calendar quarter of 2014, subject to receipt of regulatory approvals.

Logical Ink® for the iPad® Now Available in the App Store

Bottomline Technologies (NASDAQ: EPAY) today announced the availability of its Logical Ink solution for the iPad. The new app allows healthcare facilities to present patients and clinicians with Apple iPads for the completion and signing of medical forms. Once validated and signed, the discrete data they contain, as well as the documents themselves, are seamlessly transmitted to any downstream system - such as an enterprise content management (ECM) solution, electronic health record (EHR), clinical data repository, or disease registry - using industry-standard formats. By replacing paper forms with patient-friendly tablets, healthcare providers can dramatically reduce the costs and hassles of paper processing while capturing accurate patient data earlier in the cycle of care.

Invitation to noninvasive CRC screening nets highest participation rate

Colorectal cancer (CRC) screening rates in underserved patient populations can be boosted by an organized mailed outreach effort supported by telephone follow-up, according to a study published Oct. 14 in JAMA Internal Medicine.

Health Language Selected to Support DocuTAP’s Urgent Care EMR Solutions

Wolters Kluwer Health<http://distribution.mymediainfo.com/lists/lt.php?id=fB8KAVdZDVEDAk8DVwV…;, a leading global provider of information for healthcare professionals and students, announced today that DocuTAP will integrate its Health Language® applications into its electronic medical record (EMR) solution for urgent care environments. The terminology management solutions were specifically selected to address improved regulatory compliance with Stage 2 Meaningful Use and help improve accuracy and conversion to the ICD-10 coding system.

Colibri Heart Valve concludes patient enrollment in first-in-human study of proprietary TAVI system in Dominican Republic

Colibri Heart Valve, LLC, a privately held medical device company, announced that patient enrollment has concluded in the first-in-human study of the Company's transcatheter aortic valve implantation (TAVI) system in the Dominican Republic trial site. Analysis of the data from patients enrolled in this site yielded clinical outcomes that met the study's endpoints.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.